Alternative Pharmacological Strategies for the Treatment of Alzheimer’s Disease: Focus on Neuromodulator Function

Alzheimer’s disease (AD) is a neurodegenerative disorder, comprising 70% of dementia diagnoses worldwide and affecting 1 in 9 people over the age of 65. However, the majority of its treatments, which predominantly target the cholinergic system, remain insufficient at reversing pathology and act simp...

Descripción completa

Detalles Bibliográficos
Autores principales: Cunliffe, Grace, Lim, Yi Tang, Chae, Woori, Jung, Sangyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776382/
https://www.ncbi.nlm.nih.gov/pubmed/36551821
http://dx.doi.org/10.3390/biomedicines10123064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776382/
https://www.ncbi.nlm.nih.gov/pubmed/36551821
http://dx.doi.org/10.3390/biomedicines10123064

Ejemplares similares